Asymptomatic polyvascular atherosclerotic disease requires a complex management strategy--case report and review of the literature.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 20112468)

Published in J Med Life on February 01, 2010

Authors

R Jurcut1, A Florian, L Zarma, I Arsenescu, M Rosca, A Calin, C Ginghina

Author Affiliations

1: Prof Dr. C.C. Iliescu Institute of Cardiovascular Diseases, 258, Fundeni Str, Bucharest, Romania. rjurcut@gmail.com

Associated clinical trials:

Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) | NCT00004732

Articles cited by this

Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med (2006) 12.90

Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med (2004) 12.58

Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) Lancet (1998) 10.64

30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet (2006) 7.88

The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med (2000) 4.67

Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg (2006) 3.77

Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital. J Am Coll Cardiol (2001) 3.13

Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation (2001) 2.60

Causes and severity of ischemic stroke in patients with internal carotid artery stenosis. JAMA (2000) 2.56

ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. Circulation (2009) 2.47

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation (2006) 2.42

International carotid stenting study: protocol for a randomised clinical trial comparing carotid stenting with endarterectomy in symptomatic carotid artery stenosis. Cerebrovasc Dis (2004) 2.32

Endovascular treatment of the subclavian artery: stent implantation with or without predilatation. Catheter Cardiovasc Interv (2004) 1.79

Outcome in patients with asymptomatic neck bruits. N Engl J Med (1986) 1.73

Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg (2004) 1.71

Carotid angioplasty and stenting versus carotid endarterectomy for treatment of asymptomatic carotid stenosis: a randomized trial in a community hospital. Neurosurgery (2004) 1.69

Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation (1998) 1.65

Realizing the potential of carotid artery stenting: proposed paradigms for patient selection and procedural technique. Circulation (2006) 1.64

Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ: 1-year results in the CABERNET trial. Catheter Cardiovasc Interv (2008) 1.57

Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial. J Vasc Surg (1998) 1.53

Carotid Revascularization Using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J Vasc Surg (2005) 1.29

Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation (2004) 1.24

Trends in the in-hospital stroke rate following carotid endarterectomy in California and Maryland. J Vasc Surg (2006) 1.14

The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting. Catheter Cardiovasc Interv (2007) 1.12

Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Catheter Cardiovasc Interv (2006) 1.04

Carotid stenting. Circulation (2006) 0.86

Atherosclerotic Peripheral Vascular Disease Symposium II: controversies in carotid artery revascularization. Circulation (2008) 0.83

Stenting for carotid-artery stenosis. N Engl J Med (2004) 0.82

Treatment of asymptomatic carotid artery disease: similar early outcomes after carotid stenting for high-risk patients and endarterectomy for standard-risk patients. J Vasc Surg (2006) 0.81

Articles by these authors

(truncated to the top 100)

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum (1991) 11.66

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol (1994) 11.17

Striking prevalence of ankylosing spondylitis in "healthy" w27 positive males and females. N Engl J Med (1975) 4.25

Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum (1997) 4.14

Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol (1994) 4.00

Clinical history as a screening test for ankylosing spondylitis. JAMA (1977) 3.60

Sex ratio in the spondyloarthropathies and its relationship to phenotypic expression, mode of inheritance and age at onset. J Rheumatol (1993) 3.39

Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. J Rheumatol (1999) 2.12

Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J Rheumatol (1997) 2.11

Bone loss as well as bone formation is a feature of progressive ankylosing spondylitis. Br J Rheumatol (1990) 2.03

Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum (1981) 1.97

The hand radiograph as a diagnostic discriminant between seropositive and seronegative 'rheumatoid arthritis': a controlled study. Ann Rheum Dis (1983) 1.96

Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis (2000) 1.92

Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet (2001) 1.82

Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol (2001) 1.82

The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum (1998) 1.80

HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis (1996) 1.79

An "experimental" epidemic of Reiter's syndrome revisited. Follow-up evidence on genetic and environmental factors. Ann Intern Med (1976) 1.74

The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol (1996) 1.73

Total hip arthroplasty in ankylosing spondylitis: outcome in 340 patients. J Rheumatol (2001) 1.71

Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N Engl J Med (1981) 1.69

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Arthritis Rheum (2001) 1.68

The chronicity of symptoms and disability in Reiter's syndrome. An analysis of 131 consecutive patients. Ann Intern Med (1979) 1.53

A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI) J Rheumatol (1995) 1.49

A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum (1998) 1.41

The natural history of ankylosing spondylitis: is the disease really changing? J Rheumatol (1989) 1.40

Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet (1990) 1.39

Increasing age at presentation for patients with ankylosing spondylitis. Ann Rheum Dis (1992) 1.39

Atypical antineutrophil cytoplasmic antibodies in patients with ankylosing spondylitis. Br J Rheumatol (1995) 1.38

Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. J Rheumatol (1999) 1.28

Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial. Rheumatology (Oxford) (1999) 1.28

Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls. Arthritis Rheum (1983) 1.25

Reiter's syndrome following epidemic shigellosis. J Rheumatol (1982) 1.23

HLA-B27: to type of not to type? Ann Intern Med (1980) 1.23

Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol (1983) 1.23

The retroperitoneal incision. An evaluation of postoperative flank 'bulge'. Arch Surg (1994) 1.23

Selective IgA deficiency and spondyloarthropathy: a distinct disease? Ann Rheum Dis (1990) 1.20

Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men. J Rheumatol (1990) 1.20

The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade). Rheumatology (Oxford) (2004) 1.17

Ankylosing spondylitis in women and men: a case-control study. J Rheumatol (1983) 1.15

The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum (1998) 1.14

Small vessel replacement with gore-tex (expanded polytetrafluoroethylene). Arch Surg (1976) 1.14

Search for Reiter's syndrome after an outbreak of Shigella sonnei dysentery. J Rheumatol (1980) 1.13

Is disease severity in ankylosing spondylitis genetically determined? Arthritis Rheum (2001) 1.10

Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group. Ann Rheum Dis (2003) 1.08

Non-B27 MHC associations of ankylosing spondylitis. Genes Immun (2006) 1.06

Ankylosing spondylitis: the correlation between a new metrology score and radiology. Br J Rheumatol (1995) 1.06

Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis. Hum Mol Genet (2000) 1.05

Socioeconomic status in ankylosing spondylitis: relationship between occupation and disease activity. J Rheumatol (1997) 1.04

The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the bath ankylosing spondylitis radiology hip index. J Rheumatol (2000) 1.01

An update on the Bath Ankylosing Spondylitis Disease Activity and Functional Indices (BASDAI, BASFI): excellent Cronbach's alpha scores. J Rheumatol (1996) 0.99

The epidemiology of spondylodiscitis in ankylosing spondylitis--a controlled study. Br J Rheumatol (1996) 0.99

New light on uveitis in ankylosing spondylitis. J Rheumatol (1991) 0.99

Ankylosing spondylitis. Clin Rheum Dis (1985) 0.99

Double-bind cross-over tiral of flurbiprofen and phenylbutazone in ankylosing spondylitis. Br Med J (1974) 0.99

The prevalence and nature of back pain in an industrial complex: a questionnaire and radiographic and HLA analysis. Spine (Phila Pa 1976) (1980) 0.99

Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. J Rheumatol (1996) 0.97

Letter: "Ankylosing rheumatoid arthritis", ankylosing spondylitis, and HL-A antigens. Lancet (1974) 0.97

Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors. J Rheumatol (2001) 0.97

The natural history of ankylosing spondylitis. Does it burn out? J Rheumatol (1993) 0.97

Willingness to accept risk in the treatment of rheumatic disease. J Epidemiol Community Health (1990) 0.96

Aortitis in ankylosing spondylitis: early detection of aortic root abnormalities with two dimensional echocardiography. Am J Cardiol (1982) 0.94

Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized trial. Ann Intern Med (1985) 0.94

Coarctation of the aorta in adults: what is the best treatment? Case report and literature review. J Med Life (2011) 0.93

Ankylosing spondylitis sine sacroiliitis. Arthritis Rheum (1979) 0.93

Presence of circulation immune complexes in Reiter's syndrome and ankylosing spondylitis. Clin Immunol Immunopathol (1981) 0.93

Bath Ankylosing Spondylitis Functional Index. Br J Rheumatol (1995) 0.92

Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis. Ann Rheum Dis (1994) 0.92

The X-chromosome and susceptibility to ankylosing spondylitis. Arthritis Rheum (2000) 0.92

Exercise in ankylosing spondylitis: how much is optimum? J Rheumatol (1998) 0.91

The case against seronegative rheumatoid arthritis. Am J Med (1981) 0.91

Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol (1999) 0.91

Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis. Arthritis Rheum (1998) 0.90

Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Bull Rheum Dis (1982) 0.90

Late onset ankylosing spondylitis--a distinct disorder? Br J Rheumatol (1991) 0.88

Perception of prescription drug risks: a survey of patients with ankylosing spondylitis. J Rheumatol (1990) 0.88

The close correlation between symptoms and disease expression in HLA B27 positive individuals. J Rheumatol (1977) 0.88

Sustained improvement of intractable rheumatoid arthritis after total lymphoid irradiation. Arthritis Rheum (1983) 0.87

Reactive arthritis. Br Med J (1980) 0.87

Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriers. Neurology (2011) 0.87

The changing epidemiology of rheumatic diseases: should ankylosing spondylitis now be included? Br J Rheumatol (1990) 0.87

Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis (1994) 0.87

A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis. Arthritis Rheum (1989) 0.86

Reiter's syndrome. Med Clin North Am (1977) 0.86

Workshop III. Management of Reiter's syndrome. Ann Rheum Dis (1979) 0.86

Raised serum creatine phosphokinase activity in ankylosing spondylitis. Ann Rheum Dis (1975) 0.86

Low dose amitriptyline in ankylosing spondylitis: a short term, double blind, placebo controlled study. J Rheumatol (1997) 0.86

The effect of transforming growth factor beta1 gene polymorphisms in ankylosing spondylitis. Rheumatology (Oxford) (2003) 0.85

Perspectives on plant photorespiratory metabolism. Plant Biol (Stuttg) (2012) 0.85

A case-control study of juvenile- and adult-onset ankylosing spondylitis. J Rheumatol (1983) 0.84

Bacterial endocarditis presenting as acute monoarthritis. Ann Rheum Dis (1988) 0.83

Primary ankylosing spondylitis, psoriatic and enteropathic spondyloarthropathy: a controlled analysis. J Rheumatol (1991) 0.83

Juvenile onset ankylosing spondylitis--more girls than we thought? J Rheumatol (1997) 0.83

Bronchorrhoea. Br Med J (1972) 0.83

Ankylosing spondylitis and epidemic Reiter's syndrome: genetics and environment [Proceedings]. Ann Rheum Dis (1976) 0.83

Porphyria cutanea tarda associated with methotrexate therapy. Br J Rheumatol (1993) 0.83

Rarity of nephropathy in ankylosing spondylitis. Arthritis Rheum (1982) 0.83

Ankylosing rheumatoid arthritis. Rheumatol Rehabil (1975) 0.82

Survival, alcohol and deaths in ankylosing spondylitis. Br J Rheumatol (1998) 0.82

Arthritis in a patient with mycosis fungoides: complete remission after radiotherapy. Arthritis Rheum (1979) 0.81